Ferritin heavy chain in triple negative breast cancer: A favorable prognostic marker that relates to a cluster of differentiation 8 positive (CD8+) effector t-cell response

Molecular and Cellular Proteomics

Volumn 13, Issue 7, 2014, Pages 1814-1827

  Liu, Ning Qing ^b,c,f   De Marchi, Tommaso ^a,b   Timmermans, Annemieke M ^a   Beekhof, Robin ^a   Trapman Jansen, Anita M A C ^a   Foekens, Renée ^a   Look, Maxime P ^a   Van Deurzen, Carolien H M ^b   Span, Paul N ^c   Sweep, Fred C G J ^d   Brask, Julie Benedicte ^e   Timmermans Wielenga, Vera ^e   Debets, Reno ^a   Martens, John W M ^a,f   Foekens, John A ^a,f   Umar, Arzu ^a,f  

^a ERASMUS MC CANCER INSTITUTE   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^e Mental Health Center Glostrup   (Denmark)

^f NETHERLANDS PROTEOMICS CENTRE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; FERRITIN HEAVY CHAIN; GAMMA INTERFERON; TRANSCRIPTOME; UNCLASSIFIED DRUG; APOFERRITIN; FTH1 PROTEIN, HUMAN; TUMOR MARKER;

ADAPTIVE IMMUNITY; ADULT; AGED; APOPTOSIS; ARTICLE; CANCER PATIENT; CANCER PROGNOSIS; CANCER TISSUE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; COMPUTER MODEL; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOPLASM; EFFECTOR CELL; FEMALE; GENE EXPRESSION PROFILING; HEAVY CHAIN; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; MASS SPECTROMETRY; MIDDLE AGED; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEOMICS; SIGNAL TRANSDUCTION; TISSUE MICROARRAY; TRIPLE NEGATIVE BREAST CANCER; TUMOR IMMUNITY; BIOSYNTHESIS; CELL NUCLEUS; IMMUNOLOGY; METABOLISM; MORTALITY; PROGNOSIS; PROTEIN PROTEIN INTERACTION;

ADULT; AGED; APOFERRITINS; BIOMARKERS, TUMOR; CD8-POSITIVE T-LYMPHOCYTES; CELL NUCLEUS; CYTOPLASM; FEMALE; FERRITINS; HUMANS; INTERFERON-GAMMA; MIDDLE AGED; PROGNOSIS; PROTEIN INTERACTION MAPS; PROTEOMICS; TISSUE ARRAY ANALYSIS; TRIPLE NEGATIVE BREAST NEOPLASMS;

EID: 84904088682     PISSN: 15359476     EISSN: 15359484     Source Type: Journal    
DOI: 10.1074/mcp.M113.037176     Document Type: Article

References (53)

1. Dent, R., Trudeau, M., Pritchard, K. I., Hanna, W. M., Kahn, H. K., Sawka, C. A., Lickley, L. A., Rawlinson, E., Sun, P., and Narod, S. A. (2007) Triple-negative breast cancer: clinical features and patterns of recurrence. Clin. Cancer Res. 13, 4429-4434 (Pubitemid 47219710)
2. Rody, A., Karn, T., Liedtke, C., Pusztai, L., Ruckhaeberle, E., Hanker, L., Gaetje, R., Solbach, C., Ahr, A., Metzler, D., Schmidt, M., Müller, V., Holtrich, U., and Kaufmann, M. (2011) A clinically relevant gene signature in triple negative and basal-like breast cancer. Breast Cancer Res. 13, R97
3. Hallett, R. M., Dvorkin-Gheva, A., Bane, A., and Hassell, J. A. (2012) A Gene Signature for Predicting Outcome in Patients with Basal-like Breast Cancer. Sci. Rep. 2, 227
4. Yau, C., Esserman, L., Moore, D. H., Waldman, F., Sninsky, J., and Benz, C. C. (2010) A multigene predictor of metastatic outcome in early stage hormone receptor-negative and triple-negative breast cancer. Breast Cancer Res. 12, R85
5. Liu, N. Q., Stingl, C., Look, M. P., Smid, M., Braakman, R. B. H., De Marchi, T., Sieuwerts, A. M., Span, P. N., Sweep, F. C. G. J., Linderholm, B. K., Mangia, A., Paradiso, A., Dirix, L. Y., Van Laere, S. J., Luider, T. M., Martens, J. W. M., Foekens, J. A., and Umar, A. (2014) Comparative proteome analysis revealing an 11-protein signature for aggressive triple negative breast cancer. J. Natl. Cancer Inst. 106, djt376
6. Warmoes, M., Jaspers, J. E., Pham, T. V., Piersma, S. R., Oudgenoeg, G., Massink, M. P. G., Waisfisz, Q., Rottenberg, S., Boven, E., Jonkers, J., and Jimenez, C. R. (2012) Proteomics of mouse BRCA1-deficient mammary tumors identifies DNA repair proteins with potential diagnostic and prognostic value in human breast cancer. Mol. Cell. Proteomics 11, M111.013334
7. Geiger, T., Madden, S. F., Gallagher, W. M., Cox, J., and Mann, M. (2012) Proteomic portrait of human breast cancer progression identifies novel prognostic markers. Cancer Res. 72, 2428-2439
8. Umar, A., Kang, H., Timmermans, A. M., Look, M. P., Meijer-van Gelder, M. E., Den Bakker, M. A., Jaitly, N., Martens, J. W. M., Luider, T. M., Foekens, J. A., and Pasa-Tolić, L. (2009) Identification of a putative protein profile associated with tamoxifen therapy resistance in breast cancer. Mol Cell Proteomics 8, 1278-1294
9. Ambrosino, C., Tarallo, R., Bamundo, A., Cuomo, D., Franci, G., Nassa, G., Paris, O., Ravo, M., Giovane, A., Zambrano, N., Lepikhova, T., Jänne, O. A., Baumann, M., Nyman, T. A., Cicatiello, L., and Weisz, A. (2010) Identification of a hormone-regulated dynamic nuclear actin network associated with estrogen receptor alpha in human breast cancer cell nuclei. Mol. Cell. Proteomics 9, 1352-1367
10. Cha, S., Imielinski, M. B., Rejtar, T., Richardson, E. A., Thakur, D., Sgroi, D. C., and Karger, B. L. (2010) In situ proteomic analysis of human breast cancer epithelial cells using laser capture microdissection: annotation by protein set enrichment analysis and gene ontology. Mol. Cell. Proteomics 9, 2529-2544
11. Michalski, A., Cox, J., and Mann, M. (2011) More than 100,000 detectable peptide species elute in single shotgun proteomics runs but the majority is inaccessible to data-dependent LC-MS/MS. J. Proteome Res. 10, 1785-1793
12. Knovich, M. A., Storey, J. A., Coffman, L. G., Torti, S. V., and Torti, F. M. (2009) Ferritin for the clinician. Blood Rev. 23, 95-104
13. Shpyleva, S. I., Tryndyak, V. P., Kovalchuk, O., Starlard-Davenport, A., Chekhun, V. F., Beland, F. a, and Pogribny, I. P. (2011) Role of ferritin alterations in human breast cancer cells. Breast Cancer Res. Treat. 126, 63-71
14. Pham, C. G., Bubici, C., Zazzeroni, F., Papa, S., Jones, J., Alvarez, K., Jayawardena, S., De Smaele, E., Cong, R., Beaumont, C., Torti, F. M., Torti, S. V., and Franzoso, G. (2004) Ferritin heavy chain upregulation by NF-kappaB inhibits TNFalpha-induced apoptosis by suppressing reactive oxygen species. Cell 119, 529-542 (Pubitemid 39482352)
15. Kiessling, M. K., Klemke, C. D., Kaminski, M. M., Galani, I. E., Krammer, P. H., and Gülow, K. (2009) Inhibition of constitutively activated nuclear factor-kappaB induces reactive oxygen species- and iron-dependent cell death in cutaneous T-cell lymphoma. Cancer Res. 69, 2365-2374
16. Liu, F., Du, Z.-Y., He, J.-L., Liu, X.-Q., Yu, Q.-B., and Wang, Y.-X. (2012) FTH1 binds to Daxx and inhibits Daxx-mediated cell apoptosis. Mol. Biol. Rep. 39, 873-879
17. Gray, C. P., Arosio, P., and Hersey, P. (2003) Association of Increased Levels of Heavy-Chain Ferritin with Increased CD4 + CD25 + Regulatory T-Cell Levels in Patients with Melanoma Association of Increased Levels of Heavy-Chain Ferritin with Patients with Melanoma 1. Clin. Cancer Res. 9, 2551-2559 (Pubitemid 36842096)
18. Halpern, M., Zahalka, M. A., Traub, L., and Moroz, C. (2007) Antibodies to Placental Immunoregulatory Ferritin with Transfer of Polyclonal Lymphocytes Arrest MCF-7 Human Breast Cancer Growth in a Nude Mouse Model. Neoplasia 9, 487-494 (Pubitemid 46983451)
19. Wang, Y., Klijn, J. G. M., Zhang, Y., Sieuwerts, A. M., Look, M. P., Yang, F., Talantov, D., Timmermans, M., Meijer-van Gelder, M. E., Yu, J., Jatkoe, T., Berns, E. M. J. J., Atkins, D., and Foekens, J. A. (2005) Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet 365, 671-679 (Pubitemid 40260888)
20. Minn, A. J., Gupta, G. P., Padua, D., Bos, P., Nguyen, D. X., Nuyten, D., Kreike, B., Zhang, Y., Wang, Y., Ishwaran, H., Foekens, J. A., Van de Vijver, M., and Massagué, J. (2007) Lung metastasis genes couple breast tumor size and metastatic spread. Proc. Natl. Acad. Sci. U.S.A. 104, 6740-6745 (Pubitemid 47175571)
21. Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., and Mesirov, J. P. (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. U.S.A. 102, 15545-15550 (Pubitemid 41528093)
22. Lehmann, B. D., Bauer, J. A., Chen, X., Sanders, M. E., Chakravarthy, A. B., Shyr, Y., and Pietenpol, J. A. (2011) Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. J. Clin. Invest. 121, 2750-2767
23. Liberzon, A., Subramanian, A., Pinchback, R., Thorvaldsdóttir, H., Tamayo, P., and Mesirov, J. P. (2011) Molecular signatures database (MSigDB) 3.0. Bioinformatics 27, 1739-1740
24. Merico, D., Isserlin, R., Stueker, O., Emili, A., and Bader, G. D. (2010) Enrichment map: a network-based method for gene-set enrichment visualization and interpretation. PloS One 5, e13984
25. Franceschini, A., Szklarczyk, D., Frankild, S., Kuhn, M., Simonovic, M., Roth, A., Lin, J., Minguez, P., Bork, P., Von Mering, C., and Jensen, L. J. (2013) STRING v9.1: protein-protein interaction networks, with increased coverage and integration. Nucleic Acids Res. 41, D808-D815
26. Eisen, M. B., Spellman, P. T., Brown, P. O., and Botstein, D. (1998) Cluster analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. U.S.A. 95, 14863-14868 (Pubitemid 29003722)
27. McShane, L. M., Altman, D. G., Sauerbrei, W., Taube, S. E., Gion, M., and Clark, G. M. (2005) Reporting recommendations for tumor marker prognostic studies (REMARK). J. Natl. Cancer Inst. 97, 1180-1184 (Pubitemid 41258223)
28. Elston, C. W., and Ellis, I. O. (1991) Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 19, 403-410
29. Hanahan, D., and Weinberg, R. A. (2011) Hallmarks of cancer: the next generation. Cell 144, 646-674
30. Nakayama, K. I., and Nakayama, K. (2006) Ubiquitin ligases: cell-cycle control and cancer. Nat. Rev. Cancer 6, 369-381
31. Mukhopadhyay, R., Jia, J., Arif, A., Ray, P. S., and Fox, P. L. (2009) The GAIT system: a gatekeeper of inflammatory gene expression. Trends Biochem. Sci. 34, 324-331
32. Yamano, T., Mizukami, S., Murata, S., Chiba, T., Tanaka, K., and Udono, H. (2008) Hsp90-mediated assembly of the 26 S proteasome is involved in major histocompatibility complex class I antigen processing. J. Biol. Chem. 283, 28060-28065
33. Kloetzel, P.-M. (2004) The proteasome and MHC class I antigen processing. Biochim. Biophys. Acta 1695, 225-233
34. Vyas, J. M., Van Der Veen, A. G., and Ploegh, H. L. (2008) The known unknowns of antigen processing and presentation. Nat. Rev. Immunol. 8, 607-618
35. Brivio, F., Fumagalli, L., Parolini, D., Messina, G., Rovelli, F., Rescaldani, R., Vigore, L., Vezzo, R., Vaghi, M., Di Bella, S., and Lissoni, P. (2008) T-helper/T-regulator lymphocyte ratio as a new immunobiological index to quantify the anticancer immune status in cancer patients. In vivo 22, 647-650
36. Lowery, A. J., Miller, N., McNeill, R. E., and Kerin, M. J. (2008) MicroRNAs as prognostic indicators and therapeutic targets: potential effect on breast cancer management. Clin. Cancer Res. 14, 360-365 (Pubitemid 351226101)
37. Naro, C., and Sette, C. Phosphorylation-Mediated Regulation of Alternative Splicing in Cancer. Int. J. Cell Biol. 2013, 151839, 2013
38. Vucic, D., Dixit, V. M., and Wertz, I. E. (2011) Ubiquitylation in apoptosis: a post-translational modification at the edge of life and death. Nat. Rev. Mol. Cell Biol. 12, 439-452
39. Nagaraj, N., Wisniewski, J. R., Geiger, T., Cox, J., Kircher, M., Kelso, J., Pääbo, S., and Mann, M. (2011) Deep proteome and transcriptome mapping of a human cancer cell line. Mol. Syst. Biol. 7, 548
40. Jézéquel, P., Campion, L., Spyratos, F., Loussouarn, D., Campone, M., Guérin-Charbonnel, C., Joalland, M.-P., André, J., Descotes, F., Grenot, C., Roy, P., Carlioz, A., Martin, P.-M., Chassevent, A., Jourdan, M.-L., and Ricolleau, G. (2012) Validation of tumor-associated macrophage ferritin light chain as a prognostic biomarker in node-negative breast cancer tumors: A multicentric 2004 national PHRC study. Int. J. Cancer 131, 426-437
41. Liu, S., Lachapelle, J., Leung, S., Gao, D., Foulkes, W. D., and Nielsen, T. O. (2012) CD8+ lymphocyte infiltration is an independent favorable prognostic indicator in basal-like breast cancer. Breast Cancer Res. 14, R48
42. Diederichsen, A. C. P., Hjelmborg, J. v B., Christensen, P. B., Zeuthen, J., and Fenger, C. (2003) Prognostic value of the CD4+/CD8+ ratio of tumour infiltrating lymphocytes in colorectal cancer and HLA-DR expression on tumour cells. Cancer Immunol. Immunother. 52, 423-428 (Pubitemid 36831363)
43. Galon, J., Costes, A., Sanchez-Cabo, F., Kirilovsky, A., Mlecnik, B., Lagorce-Pagès, C., Tosolini, M., Camus, M., Berger, A., Wind, P., Zinzindohoué, F., Bruneval, P., Cugnenc, P.-H., Trajanoski, Z., Fridman, W.-H., and Pagès, F. (2006) Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 313, 1960-1964 (Pubitemid 44498003)
44. Zhang, L., Conejo-Garcia, J. R., Katsaros, D., Gimotty, P. A., Massobrio, M., Regnani, G., Makrigiannakis, A., Gray, H., Schlienger, K., Liebman, M. N., Rubin, S. C., and Coukos, G. (2003) Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. N. Engl. J. Med. 348, 203-213 (Pubitemid 36077915)
45. Gray, C. P. (2002) Heavy chain ferritin activates regulatory T cells by induction of changes in dendritic cells. Blood 99, 3326-3334
46. Quezada, S. A., Peggs, K. S., Simpson, T. R., and Allison, J. P. (2011) Shifting the equilibrium in cancer immunoediting: from tumor tolerance to eradication. Immunol. Rev. 241, 104-118
47. Ward, P. A., and Varani, J. (1993) Mechanisms of neutrophil-mediated injury. Clin. Exp. Immunol. 9, 2 (Pubitemid 23276680)
48. Li, R., Luo, C., Mines, M., Zhang, J., and Fan, G.-H. (2006) Chemokine CXCL12 induces binding of ferritin heavy chain to the chemokine receptor CXCR4, alters CXCR4 signaling, and induces phosphorylation and nuclear translocation of ferritin heavy chain. J. Biol. Chem. 281, 37616-37627 (Pubitemid 46042064)
49. Luker, K. E., Lewin, S. A., Mihalko, L. A., Schmidt, B. T., Winkler, J. S., Coggins, N. L., Thomas, D. G., and Luker, G. D. (2012) Scavenging of CXCL12 by CXCR7 promotes tumor growth and metastasis of CXCR4-positive breast cancer cells. Oncogene 31, 1-9
50. Zhang, X. H.-F., Jin, X., Malladi, S., Zou, Y., Wen, Y. H., Brogi, E., Smid, M., Foekens, J. A., and Massagué, J. (2013) Selection of bone metastasis seeds by mesenchymal signals in the primary tumor stroma. Cell 154, 1060-1073
51. Taube, J. M., Anders, R. A., Young, G. D., Xu, H., Sharma, R., McMiller, T. L., Chen, S., Klein, A. P., Pardoll, D. M., Topalian, S. L., and Chen, L. (2012) Colocalization of inflammatory response with B7-h1 expression in human melanocytic lesions supports an adaptive resistance mechanism of immune escape. Sci. Transl. Med. 4, 127ra37
52. Lin, M., Rippe, R. A., Niemelä, O., Brittenham, G., and Tsukamoto, H. (1997) Role of iron in NF-kappa B activation and cytokine gene expression by rat hepatic macrophages. Am. J. Physiol. 272, G1355-G1364
53. Kaomongkolgit, R., Cheepsunthorn, P., Pavasant, P., and Sanchavanakit, N. (2008) Iron increases MMP-9 expression through activation of AP-1 via ERK/Akt pathway in human head and neck squamous carcinoma cells. Oral Oncol. 44, 587-594 (Pubitemid 351681968)